Energy & Utilities Global On demand · 24-48h

Global Nuclear Imaging Service Market Strategic Research Report

Global Nuclear Imaging Service Market Strategic Research Rep…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Nuclear Imaging Service Market
$5172025
5.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: SPECT/CT, PET/CT

By Application: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: RadNet Inc., Siemens Healthineers AG, Nueclear Healthcare Limited, MedQuest Associates, Inc. (Novant Health), Dignity Health (CommonSpirit Health), I-MED Radiology Network (Permira), Sonic Healthcare, Alliance Healthcare Services, Inc., GE Healthcare, Positron Corporation, Koninklijke Philips N.V., Bracco Imaging SPA, Cardinal Health Inc., Lantheus Medical Imaging, Bayer, Christiana Care, AdventHealth

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 129 pages
Market size 2025
$517
Million USD
Forecast CAGR
5.8%
2025-2032
Forecast 2032
$767.2
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Nuclear Imaging Service market size is predicted to grow from US$ 517 million in 2025 to US$ 762 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

Nuclear Imaging is a branch of medical imaging which uses small amounts of radioactive substances for the diagnosis and treatment of various chronic diseases. The technology is witnessing a surge in adoption, owing to the growing prevalence of target conditions.

Nuclear imaging plays a crucial role in the diagnosis, staging, and monitoring of various chronic diseases, including cancer, cardiovascular disorders, and neurological conditions. As the global burden of these diseases continues to rise, the demand for nuclear imaging services is increasing. Advances in nuclear imaging technology have improved the accuracy, resolution, and speed of imaging procedures. This includes the development of hybrid imaging techniques such as PET-CT and SPECT-CT, which provide comprehensive diagnostic information by combining anatomical and functional imaging. These technological advancements attract healthcare providers and patients to nuclear imaging services. The elderly population is more prone to chronic diseases such as cancer, dementia, and cardiovascular disorders, which often require nuclear imaging for accurate diagnosis and treatment planning. As the world"s population continues to age, the demand for nuclear imaging services is expected to increase significantly. Awareness about the importance of early disease detection and diagnosis has been rising. Nuclear imaging services, with their ability to detect diseases at an early stage and provide valuable diagnostic information, are becoming an integral part of preventive healthcare strategies. This trend is driving the market for nuclear imaging services. Personalized medicine aims to tailor medical treatments based on an individual"s unique characteristics and needs. Nuclear imaging techniques, such as PET scans, facilitate the visualization of molecular processes, enabling precise diagnosis and treatment planning tailored to each patient. The increasing demand for personalized medicine is thus boosting the market for nuclear imaging services. Reimbursement policies and insurance coverage for nuclear imaging services vary across regions. However, favorable reimbursement policies in many countries, along with increasing recognition of the clinical utility of nuclear imaging, are driving market growth by improving patient access to these services. Ongoing research and development efforts in nuclear imaging are focused on improving imaging modalities, developing new radiopharmaceuticals, and exploring innovative applications. These initiatives contribute to the expansion of the nuclear imaging service market by expanding the scope of nuclear imaging in various medical specialties.

This report presents a comprehensive overview of the global Nuclear Imaging Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • SPECT/CT
  • PET/CT

Segment by Application

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Nuclear Imaging Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Nuclear Imaging Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$517
2025
Forecast
$767.2
2032
CAGR
5.8%
2025–2032
リージョン
5
global
Key companies
RadNet Inc.Siemens Healthineers AGNueclear Healthcare LimitedMedQuest AssociatesInc. (Novant Health)Dignity Health (CommonSpirit Health)I-MED Radiology Network (Permira)Sonic Healthcare
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
SPECT/CTPET/CT
By Application
HospitalsDiagnostic Imaging CentersAmbulatory Surgical CentersOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 SPECT/CT
  • 3.1.3 PET/CT
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Diagnostic Imaging Centers
  • 4.1.4 Ambulatory Surgical Centers
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 RadNet Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Siemens Healthineers AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nueclear Healthcare Limited
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 MedQuest Associates, Inc. (Novant Health)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Dignity Health (CommonSpirit Health)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 I-MED Radiology Network (Permira)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Sonic Healthcare
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Alliance Healthcare Services, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 GE Healthcare
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Positron Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Koninklijke Philips N.V.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Bracco Imaging SPA
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Cardinal Health Inc.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Lantheus Medical Imaging
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Bayer
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Christiana Care
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 AdventHealth
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Nuclear Imaging Service market?
The global Nuclear Imaging Service market is estimated at US$ 517 million in 2025 (base year) and is projected to reach US$ 762 million by 2032.
What is the forecast CAGR for the Nuclear Imaging Service market?
The market is expected to grow at a CAGR of 5.8% from 2026 to 2032, expanding from US$ 517 million in 2025 to US$ 762 million in 2032, roughly 1.5 times its base-year value.
What is Nuclear Imaging Service?
Nuclear Imaging is a branch of medical imaging which uses small amounts of radioactive substances for the diagnosis and treatment of various chronic diseases. The technology is witnessing a surge in adoption, owing to the growing prevalence of target conditions.
How is the Nuclear Imaging Service market segmented by type?
By type, the market is segmented into SPECT/CT and PET/CT.
What are the key applications of Nuclear Imaging Service?
Key applications covered include Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers and Others.
Which companies are profiled in the Nuclear Imaging Service market report?
Key players profiled include RadNet Inc., Siemens Healthineers AG, Nueclear Healthcare Limited, MedQuest Associates, Inc. (Novant Health), Dignity Health (CommonSpirit Health), I-MED Radiology Network (Permira), Sonic Healthcare and Alliance Healthcare Services, among 17 companies covered in total.
What geographies does the Nuclear Imaging Service market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Nuclear Imaging Service?
This trend is driving the market for nuclear imaging services.
Who should buy the Nuclear Imaging Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Diagnostic Imaging Centers and Ambulatory Surgical Centers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Nuclear Imaging Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.